Christopher H. Crane

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Adjuvant Chemotherapy +/- Chemoradiotherapy for Adenocarcinoma of The Pancreatic Head: Results of The Radiotherapy Randomization of NRG Oncology/RTOG 0848

  Journal of Clinical Oncology · 2026-06-09

• Radiogenomics and the DNA damage response: opportunities for biomarker-guided radiosensitization in pancreatic cancer

  Frontiers in Oncology · 2026-06-08

• Supplementary Figure S7 from Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer

  2026-06-01

• Supplementary Table S9 from Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer

  2026-06-01

• Supplementary Figure S6 from Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer

  2026-06-01

• Supplementary Figure S4 from Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer

  2026-06-01

• Supplementary Figure S2 from Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer

  2026-06-01

• Supplementary Table S1 from Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer

  2026-06-01

• Supplementary Table S8 from Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer

  2026-06-01

• Supplementary Figure S3 from Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer

  2026-06-01

• Supplementary Figure S11 from Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer

  2026-06-01

• Supplementary Table S6 from Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer

  2026-06-01

• Supplementary Figure S8 from Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer

  2026-06-01

• Supplementary Figure S1 from Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer

  2026-06-01

• Supplementary Table S4 from Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer

  2026-06-01

• Supplementary Table S3 from Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer

  2026-06-01

• Supplementary Table S5 from Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer

  2026-06-01

• Data from Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer

  2026-06-01

• Supplementary Figure S9 from Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer

  2026-06-01

• Supplementary Table S2 from Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer

  2026-06-01